STOCK TITAN

Genethera Stock Price, News & Analysis

GTHR OTC

Company Description

Genethera (OTC: GTHR) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

GTHR stock has declined 98.3% over the past year.

This page provides a comprehensive overview of GTHR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-98.33%
Performance 1 year

Genethera (GTHR) stock. Over the past 12 months, the stock has lost 98.3%.

SEC Filings

No SEC filings available for GTHR.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

GTHR Company Profile & Sector Positioning

Genethera (GTHR) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.